Regulatory Filings • Aug 8, 2019
Regulatory Filings
Open in ViewerOpens in native device viewer
������ ������� ������ ������ ���� �� 2019 false
| ��� ������ ��������� ��"� | 2 380 |
| TEVA- PHARMACEUTICAL INDUSTRIES LTD | |
| Corporation no: 520013954 | 10817 |
| - - - | |
| Israel Securities Authority | Tel Aviv Stock Exchange | C002 ( Public ) | Reported via MAGNA: | 07/08/2019 | ||||||
| www.isa.gov.il | www.tase.co.il | Reference: | 2019-02-068229 | Time of broadcast: 23:16 23:15:47 |
Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
Attached hereto is a report on������ ������� ������ ������ ���� �� 2019
Teva_10-Q_Bannerless_isa.pdf
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): | |
| - - - | |
| Stock Exchange/Market: NYSE | Date of revision of form structure: 06/08/2019 |
| Address: P.O.B 3190 , Petach Tikva 49131 , Tel: 03-9267267 , 03-9267652 Fax: 03-9267519 | |
| E-mail address: [email protected] | |
| Previous names of reporting entity: | |
| Name of the Signatory: Beck Codner Iris Position of Signatory in the reporting corporation: Vice President, Global Corporate Communication Name of Employer Company: | |
| Address: Basel 5 , Petach Tikva 49131 Telephone: 03-9267208 Facsimile: 03-9267851 E-mail: [email protected] 1 | |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.